The Supreme Court on Wednesday asked the Andhra Pradesh High Court, which had passed an interim order staying the USD 4 billion merger of Ranbaxy with Sun Pharma, to decide the issue within two days
A US class action lawsuit accusing India's Ranbaxy of large-scale deception on its generic drug applications puts a question mark on drug imports from India, the largest supplier of generic drugs to the US
Copyright © 2024 - Odisha Television Limited All Rights Reserved.